Skip to main content Skip to office menu Skip to footer
Minnesota Legislature

THIRTY-FIRST MEETING - Health and Human Services Finance Division

2019-2020 Regular Session

STATE OF MINNESOTA THIRTY-FIRST MEETING
HOUSE OF REPRESENTATIVES NINETY-FIRST SESSION

HEALTH AND HUMAN SERVICES FINANCE DIVISION

MINUTES

Representative Liebling, Chair of the Division, called the meeting to order at 12:48 P.M. on March 26, 2019 in Room 200 of the State Office Building.

The Committee Legislative Assistant noted the roll.

Members present:
LIEBLING, Tina, Chair
MANN, Alice, Vice-Chair
SCHOMACKER, Joe, Lead Republican
ACOMB, Patty
BAKER, Dave
BIERMAN, Robert
CANTRELL, Hunter
FRANSON, Mary
GRUENHAGEN, Glenn
HALEY, Barb
HAMILTON, Rod
KUNESH-PODEIN, Mary
LOEFFLER, Diane
MORAN, Rena
MUNSON, Jeremy
NOOR, Mohamud
OLSON, Liz
SCHULTZ, Jennifer
ZERWAS, Nick

Members excused:
HALVERSON, Laurie

A quorum was present.

Representative Bierman moved that the minutes of March 21, 2019 be approved. THE MOTION PREVAILED.

HF 728 (Mann) Pharmacy benefit managers licensure and regulations created, and rulemaking authorized.

Vice Chair Mann requested that HF 728 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Vice Chair Mann moved the A19-0263 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Vice Chair Mann moved the H0728A9 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Vice Chair Mann moved the H0728A10 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Vice Chair Mann presented HF 728.

Testifiers:
1. Randy Shindelar, Chief Financial Officer, Astrup Companies
2. Sarah Greenfield, Consultant, TakeAction Minnesota
3. David Root, Prime Therapeutics
4. Bentley Graves, Policy Director, Health Care and Transportation Policy, Minnesota Chamber of Commerce

Chair Liebling laid over HF 728, as amended, for possible inclusion in the Division bill.

HF 485 (Howard) Pharmaceutical assistance program established, insulin assistance account in the special revenue fund established, fees and penalties established, and money appropriated.

Chair Liebling moved that HF 485 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Chair Liebling moved the H0485A1 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Howard presented HF 485.

Testifiers:
1. Quinn Nystrom, Diabetes Advocate
2. Nicole Smith-Holt and James Holt, parents
3. Kristina Moorhead, Senior Director of State Policy, PhRMA
4. Sara Ginsberg, Advocate
5. Debra Souther, Advocate

Chad Hope, Deputy Director, Purchasing and Service Delivery, Department of Human Services (DHS) responded to member questions.

Chair Liebling laid over HF 485, as amended, for possible inclusion in the Division bill.

At 2:16 P.M. Chair Liebling recessed the committee until 5:30 P.M. or the call of the chair.

Chair Liebling reconvened the committee at 5:35 P.M.

HF 4 (Lesch) Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.

Chair Liebling moved that HF 4 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Lesch presented HF 4.

Testifiers:
1. Dawn Burnfin, SEIU Healthcare Minnesota
2. Carly Melin, Legislative Affairs Director, Minnesota Attorney General
3. Thom Carlson, TakeAction Minnesota member
4. Judy Cook, Association for Accessible Medicines
5. Kristina Moorhead, Senior Director of State Policy, PhRMA

Chair Liebling moved the H0004A3 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Chair Liebling laid over HF 4, as amended, for possible inclusion in the Division bill.

HF 1257 (Cantrell) Prescription drug benefit transparency and disclosure required.

Representative Cantrell requested that HF 1257 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Cantrell moved the H1257A1 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Cantrell presented HF 1257.

Chair Liebling laid over HF 1257, as amended, for possible inclusion in the Division bill.

HF 1246 (Morrison) Prescription Drug Price Transparency Act established, and report required.

Chair Liebling moved that HF 1246 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Morrison presented HF 1246.

Testifiers:
1. Rick Varco, Political Director, SEIU Healthcare Minnesota
2. Judy Cook, Association for Accessible Medicines
3. Kristina Moorhead, Senior Director of State Policy, PhRMA

Chair Liebling laid over HF 1246 for possible inclusion in the Division bill.

HF 687 (Bahner) Prescription drug coverage and refills sections modified.

Chair Liebling moved that HF 687 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Bahner presented HF 687.

Testifier: Cody Wiberg, Executive Director, Minnesota Board of Pharmacy.

Chair Liebling laid over HF 687 for possible inclusion in the Division bill.

HF 815 (Acomb) Step therapy override procedures applied to state public health care programs.

Representative Acomb requested that HF 815 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Acomb presented HF 815.

Testifier: Daniel Endreson, Senior Manager of Advocacy for the National Multiple Sclerosis Society

Chair Liebling laid over HF 815 for possible inclusion in the Division bill.

HF 733 (Tabke) Security screening systems added to ionizing radiation-producing equipment, and money appropriated.

Chair Liebling moved that HF 733 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Chair Liebling moved the H0733A1 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Tabke presented HF 733.

Testifier: Tracy Beltz, Warden, Shakopee Correctional Facility

Chair Liebling laid over HF 733, as amended, for possible inclusion in the Division bill.

HF 2009 (Cantrell) Health plan companies and commissioner of human services prohibited from requiring enrollees to follow metastatic cancer step therapy protocols.
Representative requested that HF be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Cantrell moved that HF 2009 be recommended to pass and be re-referred to the Committee on Ways and Means.

Representative Cantrell moved the H2009A2-1 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Cantrell renewed his motion that HF 2009, as amended, be recommended to pass and be re-referred to the Committee on Ways & Means. THE MOTION PREVAILED.

HF 62 (Youakim) Voice response suicide prevention, crisis connection, and referral activities award directed by commissioner of health, and money appropriated.

Chair Liebling moved that HF 62 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Youakim presented HF 62.

Testifier: Sue Abderholden, Executive Director, NAMI Minnesota

Chair Liebling laid over HF 62 for possible inclusion in the Division bill.

HF 1718 (Baker) Pharmacy Practice Act clarifying changes made for veterinary compounding, licensure modified for wholesale distributors, licensure established for third-party logistics providers, and fees modified.

Representative Baker requested that HF 1718 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Baker presented HF 1718.

Testifier: Cody Wiberg, Executive Director, Board of Pharmacy

Chair Liebling laid over HF 1718 for possible inclusion in the Division bill.

HF 2171 (Davnie) Commissioner of health directed to convene working groups to examine health disparities and educational achievement links for American Indian children and children of color, report required, and money appropriated.

Chair Liebling moved that HF 2171 be heard and laid over for possible inclusion in the Health and Human Services Finance Division bill.

Representative Davnie presented HF 2171.

Testifiers:
1. Shauna Hedlund, Director of School Wellness, Minnesota Comm Care
2. Jaton White, Community Wellness Consultant and Manager, Northside Achievement Zone

Chair Liebling laid over HF 2171 for possible inclusion in the Division bill.


The meeting was adjourned at 7.17 P.M.


________________________________________________________
Representative Tina Liebling, Chair


________________________________________________________
Krysta Niedernhöfer, Committee Legislative Assistant
More Info On This Meeting..
Agenda:

Bills added: HF728 (Mann) Pharmacy benefit managers licensure and regulations created, and rulemaking authorized. HF4 (Lesch) Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed. HF485 (Howard) Pharmaceutical assistance program established, insulin assistance account in the special revenue fund established, fees and penalties established, and money appropriated. HF1246 (Morrison) Prescription Drug Price Transparency Act established, and report required. HF1523 (Cantrell) Commissioner of human services directed to establish prescription drug purchasing program, and program authority and eligibility requirements specified. HF1257 (Cantrell) Prescription drug benefit transparency and disclosure required. HF687 (Bahner) Prescription drug coverage and refills sections modified. HF815 (Acomb) Step therapy override procedures applied to state public health care programs. HF2009 (Cantrell) Health plan companies and commissioner of human services prohibited from requiring enrollees to follow metastatic cancer step therapy protocols. *HF733 (Tabke) Security screening systems added to ionizing radiation-producing equipment, and money appropriated. *HF2171 (Davnie) Commissioner of health directed to convene working groups to examine health disparities and educational achievement links for American Indian children and children of color, report required, and money appropriated. *HF62 (Youakim) Voice response suicide prevention, crisis connection, and referral activities award directed by commissioner of health, and money appropriated. *HF1718 (Baker) Pharmacy Practice Act clarifying changes made for veterinary compounding, licensure modified for wholesale distributors, licensure established for third-party logistics providers, and fees modified. Bills may be added or removed.

Bills Added:
  • HF728 (Mann) - Pharmacy benefit managers licensure and regulations created, and rulemaking authorized.
  • HF4 (Lesch) - Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.
  • HF485 (Howard) - Pharmaceutical assistance program established, insulin assistance account in the special revenue fund established, fees and penalties established, and money appropriated.
  • HF1246 (Morrison) - Prescription Drug Price Transparency Act established, and report required.
  • HF1523 (Cantrell) - Commissioner of human services directed to establish prescription drug purchasing program, and program authority and eligibility requirements specified.
  • HF1257 (Cantrell) - Prescription drug benefit transparency and disclosure required.
  • HF687 (Bahner) - Prescription drug coverage and refills sections modified.
  • HF815 (Acomb) - Step therapy override procedures applied to state public health care programs.
  • HF2009 (Cantrell) - Health plan companies and commissioner of human services prohibited from requiring enrollees to follow metastatic cancer step therapy protocols.
  • HF733 (Tabke) - Security screening systems added to ionizing radiation-producing equipment, and money appropriated.
  • HF2171 (Davnie) - Commissioner of health directed to convene working groups to examine health disparities and educational achievement links for American Indian children and children of color, report required, and money appropriated.
  • HF62 (Youakim) - Voice response suicide prevention, crisis connection, and referral activities award directed by commissioner of health, and money appropriated.
  • HF1718 (Baker) - Pharmacy Practice Act clarifying changes made for veterinary compounding, licensure modified for wholesale distributors, licensure established for third-party logistics providers, and fees modified.
Hearing Documents:
Audio Available:
Listen Now